You are here: Home » Companies » News
Business Standard

Lupin launches drug to control postpartum hemorrhage after USFDA nod

Lupin's product is the generic equivalent of Novartis Pharmaceuticals Corp's Methergine

Press Trust of India  |  New Delhi 

Lupin

on Monday launched Methylergonovine Maleate tablets, used for prevention and control of postpartum hemorrhage, in the American market.

The company has launched the product in the US after having received approval from the (USFDA) earlier, said in a statement.

Lupin's product is the generic equivalent of Novartis Pharmaceuticals Corp's Methergine which is indicated for prevention and control of postpartum hemorrhage.

As per the latest industry estimates, Methylergonovine Maleate tablets had annual sales of around  $71.5 million in the US.

shares were trading 1.18 per cent up at Rs 772.10 on BSE.

First Published: Mon, June 04 2018. 17:16 IST
RECOMMENDED FOR YOU